Vitrolife AB (FRA:VTFN) Debt-to-Asset : 0.12 (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB Debt-to-Asset?

Vitrolife AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €10.5 Mil. Vitrolife AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €172.4 Mil. Vitrolife AB's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was €1,491.0 Mil. Vitrolife AB's debt to asset for the quarter that ended in Mar. 2024 was 0.12.

Vitrolife AB Debt-to-Asset Historical Data

The historical data trend for Vitrolife AB's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Debt-to-Asset Chart

Vitrolife AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.04

0.03

0.13

0.11

0.13

Vitrolife AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial															0.10	0.11	0.10	0.13	0.12

Competitive Comparison of Vitrolife AB's Debt-to-Asset

For the Medical Devices subindustry, Vitrolife AB's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vitrolife AB's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Debt-to-Asset falls into.

Vitrolife AB Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Vitrolife AB's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(13.141	+	173.609)	/	1459.766
	=	0.13

Vitrolife AB's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(10.515	+	172.401)	/	1490.992
	=	0.12

Vitrolife AB (FRA:VTFN) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Vitrolife AB Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Vitrolife AB (FRA:VTFN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (FRA:VTFN) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

VITR:Sweden 0YAY:UK

Address

Box 9080, Gothenburg, SWE, 400 92

Website

https://www.vitrolife.com

Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (FRA:VTFN) Headlines

No Headlines